Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Transplant Cell Ther. 2022 Dec 13;29(3):206.e1–206.e7. doi: 10.1016/j.jtct.2022.12.004

Table 3:

Conditional logistic regression analyses of associations with nocardiosis in allogeneic recipients

Variable Univariable analyses Multivariable analysis
Odds ratio 95% CI p-value Odds ratio 95% CI p-value
Prophylaxisa 0.23 0.06–0.87 .030 0.18 0.05–0.70 .013
GVHD requiring current immunosuppression 7.96 1.70–37.20 .008 11.09 2.09–58.75 .005
Prednisone dose ≥20 mg/day 3.68 1.23–11.01 .020
Lymphopeniab 10.7 2.17–52.75 .004
Retransplant 1.42 0.33–6.07 .637
Reduced intensity conditioning 1.97 0.54–7.21 .308
Recent CMV infectionc 4.00 1.00–15.99 .049
Recent invasive fungal infectionc 12.00 1.25–115.36 .031
Morphologic remission 0.39 0.10–1.49 .168

Bold values indicate p <0.05

Abbreviations: CI, confidence interval; CMV, cytomegalovirus; GVHD, graft-versus-host disease.

a

Includes current use of trimethoprim-sulfamethoxazole and/or doxycycline.

b

Lymphocyte count <0.5 x109/L.

c

Within 6 months before the index date.